Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.58B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
Costco
COST
|
+$680M |
| 4 |
Booking.com
BKNG
|
+$647M |
| 5 |
Broadcom
AVGO
|
+$559M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$355M |
| 2 |
Walmart Inc
WMT
|
+$348M |
| 3 |
Zoom
ZM
|
+$321M |
| 4 |
Merck
MRK
|
+$303M |
| 5 |
Lyft
LYFT
|
+$250M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.29% |
| 2 | Financials | 14.55% |
| 3 | Industrials | 13.75% |
| 4 | Consumer Discretionary | 11.6% |
| 5 | Healthcare | 11.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
Atlanta Braves Holdings Series B
BATRK
$3.37B
| $1.07M | ﹤0.01% |
25,139
+167
| +0.7% | +$6.94K |
|
2727
Hippo Holdings
HIPO
$877M
| $1.07M | ﹤0.01% |
41,002
+16,985
| +71% | +$484K |
|
2728
Velocity Financial
VEL
$728M
| $1.07M | ﹤0.01% |
58,906
-16,158
| -22% | -$305K |
|
2729
Citizens & Northern Corp
CZNC
$466M
| $1.06M | ﹤0.01% |
47,616
-531
| -1% | -$11.8K |
|
2730
Omnicell
OMCL
$1.58B
| $1.06M | ﹤0.01% |
31,853
-11,067
| -26% | -$463K |
|
2731
Compass Therapeutics
CMPX
$432M
| $1.06M | ﹤0.01% |
200,428
+45,210
| +29% | +$261K |
|
2732
CRISPR Therapeutics
CRSP
$5.52B
| $1.06M | ﹤0.01% |
22,268
+1,522
| +7% | +$80.3K |
|
2733
Blend Labs
BLND
$355M
| $1.06M | ﹤0.01% |
623,106
+495,225
| +387% | +$1.06M |
|
|
KW
2734
DELISTED
Kennedy-Wilson Holdings
KW
| $1.06M | ﹤0.01% |
97,860
+4,458
| +5% | +$46.2K |
|
2735
InterContinental Hotels
IHG
$24B
| $1.06M | ﹤0.01% |
+7,928
| New | +$1.09M |
|
2736
Colony Bankcorp
CBAN
$454M
| $1.06M | ﹤0.01% |
52,909
+5,773
| +12% | +$113K |
|
2737
Spyre Therapeutics
SYRE
$9.4B
| $1.05M | ﹤0.01% |
20,874
+3,054
| +17% | +$115K |
|
2738
Forrester Research
FORR
$228M
| $1.05M | ﹤0.01% |
185,922
+87,257
| +88% | +$596K |
|
2739
Alkami Technology
ALKT
$2.17B
| $1.05M | ﹤0.01% |
67,149
-8,486
| -11% | -$156K |
|
2740
JPMorgan Active Growth ETF
JGRO
$9.8B
| $1.05M | ﹤0.01% |
12,434
-1,515
| -11% | -$135K |
|
2741
Viemed Healthcare
VMD
$346M
| $1.05M | ﹤0.01% |
113,740
+65,440
| +135% | +$545K |
|
2742
Hudbay
HBM
$13.1B
| $1.05M | ﹤0.01% |
+52,082
| New | +$1.22M |
|
|
ACRE
2743
Ares Commercial Real Estate
ACRE
$262M
| $1.04M | ﹤0.01% |
217,540
+57,572
| +36% | +$288K |
|
2744
United Parks & Resorts
PRKS
$2.03B
| $1.04M | ﹤0.01% |
31,959
+14,835
| +87% | +$519K |
|
2745
First Trust SMID Cap Rising Dividend Achievers ETF
SDVY
$11.6B
| $1.04M | ﹤0.01% |
26,462
-2,517
| -9% | -$102K |
|
2746
VanEck Merk Gold Trust
OUNZ
$2.88B
| $1.04M | ﹤0.01% |
23,137
+7,242
| +46% | +$340K |
|
2747
iShares Global Tech ETF
IXN
$9.24B
| $1.04M | ﹤0.01% |
10,413
+5,729
| +122% | +$605K |
|
2748
Pennant Group
PNTG
$1.36B
| $1.04M | ﹤0.01% |
34,106
+13,511
| +66% | +$418K |
|
2749
Empire State Realty Trust
ESRT
$819M
| $1.04M | ﹤0.01% |
199,286
+111,562
| +127% | +$670K |
|
|
GLXY
2750
Galaxy Digital Inc
GLXY
$4.44B
| $1.04M | ﹤0.01% |
56,125
+32,772
| +140% | +$779K |
|
Similar funds
Cliff Asness's Q1 2026 Portfolio in Review
As of Q1 2026, Cliff Asness held 3,840 positions worth $218B, up 15% from $191B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Cliff Asness deployed $35.3B of net new capital in Q1 2026, opening 278 new positions and adding to 2,380 existing holdings. Its largest new stake was Versant Media Group: 5,801,568 shares worth $211M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Atlassian, an estimated $355M trimmed.
- Cliff Asness's largest Q1 2026 buy was Versant Media Group: 5,801,568 shares worth $211M.
- Cliff Asness added most to Microsoft in Q1 2026, an estimated $1.58B increase.
- Cliff Asness's biggest Q1 2026 reduction was Atlassian, cutting an estimated $355M.
- Cliff Asness fully exited Exact Sciences in Q1 2026, selling an estimated $226M.
- Cliff Asness's ten largest holdings make up 11% of its $218B portfolio in Q1 2026.
- Cliff Asness opened 278 new positions and closed 101 in Q1 2026.
- Cliff Asness's portfolio value rose 15% quarter-over-quarter to $218B.
Based on AQR Capital Management's 13F filing for Q1 2026, filed 15 May 2026.